630例冠状动脉下Ross手术患者22年瓣膜性能分类
该研究纳入1994至2017年在本机构连续接受冠状动脉下Ross手术的630例患者,中位随访12.5年(最长22.3年,共7404患者年,完整率99.4%)。20年生存率73.1%,再手术免除率85.9%,作者提出的瓣膜性能分类显示20年时79%的患者处于I或II类。
要点
- 20年生存率73.1%,与年龄性别匹配的普通人群无统计学差异
- 20年再手术免除率85.9%,自体移植物89.8%,同种移植物91.0%
- 术前环径、主动脉瓣反流、环加固、窦管交界加固及二叶式主动脉瓣类型均非再手术显著危险因素
核心结论
- 长达22年的数据表明冠状动脉下Ross手术持续提供优异的组织主动脉瓣置换效果。
- 作者提出的瓣膜性能分类成为结局分析的实用概念,20年时处于有利的I或II类的概率为79%。
研究设计与样本
- 1994年至2017年在本机构连续接受冠状动脉下Ross手术的630例患者。
- 瓣膜性能分类结合血流动力学、症状和管理标准。
- 中位随访12.5年(最长22.3年,共7404患者年,完整率99.4%)。
主要发现
- 患者平均年龄44.7±11.9岁,住院死亡0.3%(n=2)。
- 术后20年生存率73.1%(95%CI 65.4%-81.6%),与年龄性别匹配的普通人群无统计学差异。
- 20年再手术免除率85.9%(95%CI 80.2%-92.0%;每患者年0.6%),自体移植物89.8%(95%CI 84.3%-95.7%),同种移植物91.0%(95%CI 86.3%-96.0%)。
- 术前环径、主动脉瓣反流、环加固、窦管交界加固及二叶式主动脉瓣类型均非再手术的显著危险因素。
- 20年时患者处于瓣膜性能I至IV类的概率分别为5%、74%、19%和1%。
关键数值与推荐
- 二叶式与三叶式主动脉瓣的再手术时间无差异。
- 术前主动脉瓣狭窄者的自体移植物功能结局趋于更好。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To define the function of the "Ross valves" and its clinical meaning in a practical valve performance classification as part of the outcome analysis. METHODS: From 1994 to 2017, 630 consecutive patients underwent the subcoronary Ross procedure at our institution. The valve performance classification combines hemodynamics, symptoms, and management criteria. Median follow-up was 12.5 years (maximum 22.3 years, 7404 patient-years, 99.4% completeness). RESULTS: The mean age of the patients was 44.7 ± 11.9 years. Hospital deaths was 0.3% (n = 2). Twenty years after the operation survival was 73.1% (95% confidence interval [CI], 65.4%-81.6%) and statistically not different from the age- and gender-matched general population; freedom from reoperation was 85.9% (95% CI, 80.2%-92.0%; 0.6% per patient-year), 89.8% (95% CI, 84.3%-95.7%) for autograft, and 91.0% (95% CI, 86.3%-96.0%) for homograft. Preoperative annulus diameter, aortic regurgitation, annulus reinforcement, sinotubular junction reinforcement, and bicuspid aortic valve type were no significant risk factors for reoperation. At 20 years the probability of a patient being in valve performance class I to IV was 5%, 74%, 19%, and 1%, respectively. Time to reoperation was not different in bicuspid and tricuspid aortic valves; preoperative aortic stenosis tended to have better outcome of autograft function. CONCLUSIONS: These up to 22 years data show that the subcoronary Ross procedure continues to provide an excellent tissue aortic valve replacement. The suggested valve performance classification emerged as a practical concept for outcome analysis with the probability of 79% being in the favorable class I or II at 20 years.
引用
- Sievers HH, Stierle U, Petersen M, et al. Valve performance classification in 630 subcoronary Ross patients over 22 years. J Thorac Cardiovasc Surg. 2018. PMID: 29606322. doi:10.1016/j.jtcvs.2018.03.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。